Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study
about
cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsiaNew concepts of resistance in the treatment of Helicobacter pylori infectionsH pylori antibiotic resistance: prevalence, importance, and advances in testingLaboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the PhilippinesMutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in BrazilAccurate, noninvasive detection of Helicobacter pylori DNA from stool samples: potential usefulness for monitoring treatment.Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays.Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequences in 30 strains.Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from JapanSequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pyloriRoles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole.Clinical relevance and diversity of two homologous genes encoding glycosyltransferases in Helicobacter pylori.Green Synthesis of Silver Nanoparticles: Structural Features and In Vivo and In Vitro Therapeutic Effects against Helicobacter pylori Induced GastritisAntimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, IranRisk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.Helicobacter pylori detection and antimicrobial susceptibility testing.Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment FailuresVariability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern PolandMultilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian populationIntrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis.Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian NorthDistribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests.In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation studyIsolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pyloriReal-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pyloriGreen synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori.Helicobacter pylori and antibiotic resistance.
P2860
Q24550819-25E9C8DD-4F65-4E80-A9B2-65103D0789C8Q24622513-56E2B542-7DC2-48CB-AFDF-406C129BB97CQ24685864-8251DE16-C054-439D-B638-C1977370F288Q24798214-D7A3E8E7-BDD4-42DB-860B-C701CF4AEE7FQ24802227-96819338-136B-4B66-BC2B-F723533A82F1Q30453034-B64590A8-4FA5-4A35-A214-13085F0D3DB0Q33866459-BD6D5EE7-9AA5-4E6D-A137-93762DAE9630Q33972380-C9651262-3C90-4FCB-AD98-C533A05A41ACQ33980330-3BFF492D-2A1E-434C-B1C3-BB2A5D1A8B00Q33980346-6CEE7BB7-DE92-4ECB-BEEC-AB3E69A5499EQ33994585-ED328972-ED7D-4D8C-90D6-5375E48847FCQ33996752-14B3931A-C342-4DEB-92C4-14E6D2687AF8Q34046265-CD9B7919-A842-4A21-AADB-6AF7D2949A27Q34151373-05910831-BDEC-4199-9CC2-119BACDA5D3CQ34385180-A6E31843-F72E-4A80-B15A-3267B36A1BEBQ34983201-ED49ABC9-A7F8-426B-96E8-A0B9D53C6A6BQ35066862-2F0E739C-C06F-418D-9B49-80AE78C1F704Q35098365-4BB31281-CAA8-4828-BAA9-F737112BAA12Q35594635-F7AE9DA3-0C3E-4959-9347-FF0DC51647C2Q35760968-BA5A72FA-2CC6-4BE4-A8CE-2F5304EEF226Q35783436-B094128B-8584-4D02-BBE1-5A91416EB681Q35986780-58CCE0EA-167F-416C-9B88-DB5A8AEEEB9BQ36010979-36220C4E-EB1E-4754-81AB-0332A27DAFF9Q36047451-B2CB55DB-3E49-40C0-823E-6C0747AABDEFQ36474195-F55E5981-E2C1-4118-BE7B-ED7306E4AAC5Q37026545-E17F943F-8BA9-430D-989B-6F1D5E834A3DQ37059284-31FA8CB4-8296-42C5-BF18-3D58FCE02079Q37155972-E3231390-C308-4BBE-A7BF-9CEB8BFBE769Q37355104-98CF0E6E-4EA3-4E17-9E64-76D3B8660F30Q37378899-71437535-CC55-4202-9E19-05469875100AQ37558559-85947E44-A8F9-4240-BC44-82BCC1CC8DB4Q37624449-7FB89286-4448-4C16-A44C-D73D304D05CEQ37660716-B2F5FB50-3721-4598-BA32-10A0A78F01F0Q39474501-CEEBAC8E-6AF6-4A8A-BF9B-3C0FB817AD7FQ39477186-E400B57D-0167-42BC-B617-00C80AFA3F1CQ39537361-BDE764C3-6BB8-47C7-98DD-E52BD7098CA2Q39652220-F9F3B345-9536-4240-8B1C-D3733D8C48C4Q39733016-0DBC662C-461B-4916-871E-5AF233B9CB1AQ42140862-BBA42EA8-E139-4CB5-9D9C-AE159BDB9C9FQ42735860-11BAE036-13B4-49FF-8CDE-500B4134A9C8
P2860
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@ast
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@en
type
label
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@ast
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@en
prefLabel
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@ast
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@en
P2093
P2860
P356
P1476
Antimicrobial susceptibility t ...... center trial: the MACH 2 study
@en
P2093
C F Burman
C O'Morain
E Bayerdörffer
M Wrangstadh
S V van Zanten
P2860
P304
P356
10.1128/AAC.43.11.2747
P407
P577
1999-11-01T00:00:00Z